|
2022 Journal Article Landscape of epidermal growth factor receptor heterodimers in brain metastasesLim, Malcolm, Nguyen, Tam H., Niland, Colleen, Reid, Lynne E., Jat, Parmjit S., Saunus, Jodi M. and Lakhani, Sunil R. (2022). Landscape of epidermal growth factor receptor heterodimers in brain metastases. Cancers, 14 (3) 533, 533. doi: 10.3390/cancers14030533 |
|
2022 Journal Article Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour contentGanesamoorthy, Devika, Robertson, Alan James, Chen, Wenhan, Hall, Michael B., Cao, Minh Duc, Ferguson, Kaltin, Lakhani, Sunil R., Nones, Katia, Simpson, Peter T. and Coin, Lachlan J. M. (2022). Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. BMC Cancer, 22 (1) 85, 85. doi: 10.1186/s12885-021-09160-1 |
|
2022 Journal Article Blood-derived extracellular vesicle-associated miR-3182 detects non-small cell lung cancer patientsVisan, Kekoolani S., Lobb, Richard J., Wen, Shu Wen, Bedo, Justin, Lima, Luize G., Krumeich, Sophie, Palma, Carlos, Ferguson, Kaltin, Green, Ben, Niland, Colleen, Cloonan, Nicole, Simpson, Peter T., McCart Reed, Amy E., Everitt, Sarah J., MacManus, Michael P., Hartel, Gunter, Salomon, Carlos, Lakhani, Sunil R., Fielding, David and Möller, Andreas (2022). Blood-derived extracellular vesicle-associated miR-3182 detects non-small cell lung cancer patients. Cancers, 14 (1) 257, 257. doi: 10.3390/cancers14010257 |
|
2022 Book Chapter Future role of molecular profiling in small breast samples and personalised medicineFoong, Samuel Y. F., Simpson, Peter T., Cummings, Margaret C. and Lakhani, Sunil R. (2022). Future role of molecular profiling in small breast samples and personalised medicine. A comprehensive guide to core needle biopsies of the breast. (pp. 895-915) edited by Sandra J. Shin, Yunn-Yi Chen and Paula S. Ginter. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-031-05532-4_23 |
|
2021 Journal Article The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working GroupEl Bairi, Khalid, Haynes, Harry R., Blackley, Elizabeth, Fineberg, Susan, Shear, Jeffrey, Turner, Sophia, de Freitas, Juliana Ribeiro, Sur, Daniel, Amendola, Luis Claudio, Gharib, Masoumeh, Kallala, Amine, Arun, Indu, Azmoudeh-Ardalan, Farid, Fujimoto, Luciana, Sua, Luz F., Liu, Shi-Wei, Lien, Huang-Chun, Kirtani, Pawan, Balancin, Marcelo, El Attar, Hicham, Guleria, Prerna, Yang, Wenxian, Shash, Emad, Chen, I-Chun, Bautista, Veronica, Do Prado Moura, Jose Fernando, Rapoport, Bernardo L., Castaneda, Carlos, Spengler, Eunice ... The International Immuno-Oncology Biomarker Working Group (2021). The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. npj Breast Cancer, 7 (1) 150. doi: 10.1038/s41523-021-00346-1 |
|
2021 Conference Publication Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvEMcCart Reed, Amy, McCurry, Therese, Simpson, Peter, Inglis, Po-Ling, Ung, Owen, Murugappan, Kowsalya, Waddell, Nic, Snell, Cameron, Woodward, Natasha, Middleton, Kathryn, Walpole, Euan, O'Byrne, Ken, Cuff, Katharine, Andelkovic, Vladimir, Roberts, Kate, Steinke, Karin, Santamaria, Gorane, McCarthy, Nicole, Mar Fan, Helen, Kalinowski, Lauren and Lakhani, Sunil (2021). Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvE. Brisbane Cancer Conference , Brisbane, QLD Australia, 25-26 Nov 2021. |
|
2021 Journal Article The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrenceRabbie, Roy, Ferguson, Peter, Wong, Kim, Couturier, Dominique-Laurent, Moran, Una, Turner, Clinton, Emanuel, Patrick, Haas, Kerstin, Saunus, Jodi M., Davidson, Morgan R., Lakhani, Sunil R., Shivalingam, Brindha, Long, Georgina, Parkinson, Christine, Osman, Iman, Scolyer, Richard A., Corrie, Pippa and Adams, David J. (2021). The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence. British Journal of Cancer, 124 (1), 156-160. doi: 10.1038/s41416-020-01090-2 |
|
2021 Conference Publication Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvEMcCart Reed, Amy, McCurry, Therese, Simpson, Peter, Inglis, Po-ling, Ung, Owen, Murugappan, Kowsalya, Waddell, Nic, Snell, Cameron, Woodward, Natasha, Middleton, Kathryn, Walpole, Euan, O'Byrne, Ken, Cuff, Katharine, Andelkovic, Vlad, Roberts, Kate, Steinke, Karin, Santamaria, Gorane, McCarthy, Nicole, Mar Fan, Helen, Kalinowski, Lauren and Lakhani, Sunil (2021). Implementation of precision oncology for breast cancer care in Brisbane: Q-IMPROvE. Herston Symposium, Brisbane, QLD Australia, September 2021. |
|
2021 Journal Article Elevating CDCA3 levels enhances tyrosine kinase inhibitor sensitivity in TKI-resistant EGFR mutant non-small-cell lung cancerSahin, Katherine B., Shah, Esha T., Ferguson, Genevieve P., Molloy, Christopher, Kalita-de Croft, Priyakshi, Hayes, Sarah A., Hudson, Amanda, Colvin, Emily, Kamitakahara, Hannah, Harvie, Rozelle, Hasovits, Csilla, Khan, Tashbib, Duijf, Pascal H. G., Howell, Viive M., He, Yaowu, Bolderson, Emma, Hooper, John D., Lakhani, Sunil R., Richard, Derek J., O’Byrne, Kenneth J. and Adams, Mark N. (2021). Elevating CDCA3 levels enhances tyrosine kinase inhibitor sensitivity in TKI-resistant EGFR mutant non-small-cell lung cancer. Cancers, 13 (18) 4651, 4651. doi: 10.3390/cancers13184651 |
|
2021 Journal Article Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950McCart Reed, Amy E., Foong, Samuel, Kutasovic, Jamie R., Nones, Katia, Waddell, Nicola, Lakhani, Sunil R. and Simpson, Peter T. (2021). Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950. Cancers, 13 (16) 4010, 4010. doi: 10.3390/cancers13164010 |
|
2021 Journal Article SP142 PD-L1 scoring shows high interobserver and intraobserver agreement in triple-negative breast carcinoma but overall low percentage agreement with other PD-L1 clones SP263 and 22C3Pang, Jia-Min B., Castles, Belinda, Byrne, David J., Button, Peter, Hendry, Shona, Lakhani, Sunil R., Sivasubramaniam, Vanathi, Cooper, Wendy A., Armes, Jane, Millar, Ewan K.A., Raymond, Wendy, Roberts-Thomson, Samuel, Kumar, Beena, Burr, Marian, Selinger, Christina, Harvey, Kate, Chan, Charles, Beith, Jane, Clouston, David, O'Toole, Sandra A. and Fox, Stephen B. (2021). SP142 PD-L1 scoring shows high interobserver and intraobserver agreement in triple-negative breast carcinoma but overall low percentage agreement with other PD-L1 clones SP263 and 22C3. American Journal of Surgical Pathology, 45 (8), 1108-1117. doi: 10.1097/PAS.0000000000001701 |
|
2021 Journal Article Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancerTutt, Andrew N. J., Garber, Judy E., Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D., de Azambuja, Evandro, Fielding, Anitra, Balmaña, Judith, Domchek, Susan M., Gelmon, Karen A., Hollingsworth, Simon J., Korde, Larissa A., Linderholm, Barbro, Bandos, Hanna, Senkus, Elżbieta, Suga, Jennifer M., Shao, Zhimin, Pippas, Andrew W., Nowecki, Zbigniew, Huzarski, Tomasz, Ganz, Patricia A., Lucas, Peter C., Baker, Nigel, Loibl, Sibylle, McConnell, Robin, Piccart, Martine, Schmutzler, Rita ... Geyer, Charles E. (2021). Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. New England Journal of Medicine, 384 (25), 2394-2405. doi: 10.1056/NEJMoa2105215 |
|
2021 Conference Publication OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancerTutt, Andrew, Garber, Judy Ellen, Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D., de Azambuja, Evandro, Fielding, Anitra, Gelpi, Judith Balmana, Gelmon, Karen A., Baker, Nigel, Arahmani, Amal, Senkus-Konefka, Elzbieta, Mc Fadden, Eleanor, Karantza, Vassiliki, Lakhani, Sunil R., Yothers, Greg, Campbell, Christine and Geyer, Charles E. (2021). OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 04-08, 2021. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1200/JCO.2021.39.15_suppl.LBA1 |
|
2021 Journal Article Altered calcium influx pathways in cancer-associated fibroblastsSadras, Francisco, Stewart, Teneale A., Robitaille, Mélanie, Peters, Amelia A., Croft, Priyakshi Kalita-de, Soon, Patsy S., Saunus, Jodi M., Lakhani, Sunil R., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2021). Altered calcium influx pathways in cancer-associated fibroblasts. Biomedicines, 9 (6) 680, 1-13. doi: 10.3390/biomedicines9060680 |
|
2021 Journal Article Characterization of immune cell subsets of tumor infiltrating lymphocytes in brain metastasesCroft, Priyakshi Kalita-de, Chittoory, Haarika, Nguyen, Tam H., Saunus, Jodi M., Kim, Woo Gyeong, Reed, Amy E. McCart, Lim, Malcolm, De Luca, Xavier M., Ferguson, Kaltin, Niland, Colleen, Mazzieri, Roberta, Dolcetti, Riccardo, Simpson, Peter T. and Lakhani, Sunil R. (2021). Characterization of immune cell subsets of tumor infiltrating lymphocytes in brain metastases. Biology, 10 (5) 425, 425. doi: 10.3390/biology10050425 |
|
2021 Journal Article The genomic landscape of lobular breast cancerMcCart Reed, Amy E., Foong, Samuel, Kutasovic, Jamie R., Nones, Katia, Waddell, Nicola, Lakhani, Sunil R. and Simpson, Peter T. (2021). The genomic landscape of lobular breast cancer. Cancers, 13 (8) 1950, 1950. doi: 10.3390/cancers13081950 |
|
2021 Journal Article Tumor signature analysis implicates hereditary cancer genes in endometrial cancer developmentKondrashova, Olga, Shamsani, Jannah, O’Mara, Tracy A., Newell, Felicity, Reed, Amy E. McCart, Lakhani, Sunil R., Kirk, Judy, Pearson, John V., Waddell, Nicola and Spurdle, Amanda B. (2021). Tumor signature analysis implicates hereditary cancer genes in endometrial cancer development. Cancers, 13 (8) 1762, 1-16. doi: 10.3390/cancers13081762 |
|
2021 Journal Article Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for managementRakha, Emad A., Quinn, Cecily M., Foschini, Maria Pia, Munoz Martin, Monica, Dabbs, David J., Lakhani, Sunil, Varga, Zsuzsanna, Pinder, Sarah E., Schmitt, Fernando C., Reis-Filho, Jorge S., Fox, Stephen B., Ellis, Ian O., Tan, Puay-Hoon and Mihai, Raluca (2021). Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management. Histopathology, 78 (5), 759-771. doi: 10.1111/his.14290 |
|
2021 Journal Article Spatial profiling technologies and applications for brain cancersKalita-de Croft, Priyakshi, Rad, Habib Sadeghi, Gasper, Harry, O'Byrne, Ken, Lakhani, Sunil R. and Kulasinghe, Arutha (2021). Spatial profiling technologies and applications for brain cancers. Expert Review of Molecular Diagnostics, 21 (3), 323-332. doi: 10.1080/14737159.2021.1900735 |
|
2021 Journal Article CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersJohnson, Nichola, Maguire, Sarah, Morra, Anna, Kapoor, Pooja Middha, Tomczyk, Katarzyna, Jones, Michael E., Schoemaker, Minouk J., Gilham, Clare, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Ahearn, Thomas U., Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arndt, Volker, Aronson, Kristan J., Augustinsson, Annelie, Baynes, Caroline, Freeman, Laura E. Beane, Beckmann, Matthias W., Benitez, Javier, Bermisheva, Marina, Blomqvist, Carl, Boeckx, Bram, Bogdanova, Natalia V., Bojesen, Stig E., Brauch, Hiltrud, Brenner, Hermann ... Fletcher, Olivia (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4), 842-854. doi: 10.1038/s41416-020-01185-w |
